- Home
- GAME vs ACXP Comparison
GAME vs ACXP Comparison
Compare GAME & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAME
- ACXP
- Stock Information
- Founded
- GAME 2011
- ACXP 2017
- Country
- GAME United States
- ACXP United States
- Employees
- GAME N/A
- ACXP N/A
- Industry
- GAME
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- GAME
- ACXP Health Care
- Exchange
- GAME Nasdaq
- ACXP Nasdaq
- Market Cap
- GAME 23.2M
- ACXP 32.0M
- IPO Year
- GAME 2009
- ACXP 2021
- Fundamental
- Price
- GAME $0.80
- ACXP $1.96
- Analyst Decision
- GAME Strong Buy
- ACXP Strong Buy
- Analyst Count
- GAME 2
- ACXP 1
- Target Price
- GAME $4.00
- ACXP $12.00
- AVG Volume (30 Days)
- GAME 361.0K
- ACXP 40.2K
- Earning Date
- GAME 11-14-2024
- ACXP 11-13-2024
- Dividend Yield
- GAME N/A
- ACXP N/A
- EPS Growth
- GAME N/A
- ACXP N/A
- EPS
- GAME N/A
- ACXP N/A
- Revenue
- GAME $84,160,866.00
- ACXP N/A
- Revenue This Year
- GAME $113.45
- ACXP N/A
- Revenue Next Year
- GAME $19.68
- ACXP N/A
- P/E Ratio
- GAME N/A
- ACXP N/A
- Revenue Growth
- GAME 175.59
- ACXP N/A
- 52 Week Low
- GAME $0.65
- ACXP $1.52
- 52 Week High
- GAME $2.30
- ACXP $5.70
- Technical
- Relative Strength Index (RSI)
- GAME 49.55
- ACXP 42.21
- Support Level
- GAME $0.65
- ACXP $1.99
- Resistance Level
- GAME $1.15
- ACXP $2.14
- Average True Range (ATR)
- GAME 0.08
- ACXP 0.10
- MACD
- GAME 0.03
- ACXP -0.01
- Stochastic Oscillator
- GAME 29.80
- ACXP 22.58
About GAME GameSquare Holdings Inc.
GameSquare Holdings Inc is a vertically integrated, digital media, entertainment and technology company that connects brands with gaming and youth culture audiences. The company's end-to-end platform includes Gaming Community Network (a "GCN"), a digital media company focused on gaming and esports audiences, Swingman LLC dba as Zoned, a gaming and lifestyle marketing agency, and Code Red Esports Ltd. The company's geographical segment includes the United Kingdom, the USA, and Spain. The company generates the majority of its revenue from the USA. The company's sources of revenue consist of Teams, Agency, and SaaS + Advertising.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.